Does this study prove PRP works for knee arthritis?

No. Both groups received PRP and there was no placebo group, so the trial only shows that the standardized pathway did better than usual PRP care, not that PRP itself is effective.

Who was included in the trial?

240 patients with early knee osteoarthritis, rated Kellgren-Lawrence grade I or II, treated at 3 hospitals in China.

Research Summary

A Standardized PRP Care Pathway Beat Usual PRP Care for Early Knee Arthritis in a 240-Patient Trial

By KneePainNews Editorial Team · November 2, 2026 · Editorial Standards

Not medical advice. This is a plain-English summary for general information. Talk to your doctor or physical therapist before changing your care. Read our medical disclaimer.

How PRP is delivered may matter: a standardized care pathway produced better 12-month pain and function results than usual PRP care in people with early knee osteoarthritis. The randomized trial was published in the American Journal of Sports Medicine in October 2026.

What was studied

Platelet-rich plasma (PRP) injections give mixed results in research. Researchers at 3 hospitals in China wanted to know whether a structured, quality-controlled approach would do better than PRP given however each physician usually does it.

They randomized 240 patients with mild knee osteoarthritis (Kellgren-Lawrence grade I or II) to a standardized pathway (120) or conventional PRP care (120). The pathway combined standardized patient selection, quality-controlled leukocyte-poor PRP, ultrasound-guided injections, staged rehabilitation and systematic follow-up. The trial was double-blind.

Key findings

At 12 months, the pathway group improved about 3 points more on a 10-point pain scale and also did better on WOMAC and IKDC knee function scores.
More pathway patients reached improvements considered clinically meaningful, and satisfaction was higher.
Side effects were less common with the pathway: 14.8% versus 31.9%.
Average costs were similar between groups.

What it means for people with knee pain

If you are considering PRP for early knee arthritis, it may be worth asking how it is prepared and given, for example whether injections are ultrasound-guided and paired with a rehab plan. This study suggests the overall package of care can affect results.

Limitations

There was no placebo group, and all parts of the pathway were bundled together, so the trial cannot show whether PRP itself works or which component made the difference. It included only early-stage arthritis and was conducted in China, so results may not apply everywhere.

Source: Yang S, Wang H, Liu Y, Fu F, Xu P, Li Q, Li J, Tian X, Chen G. Clinical Pathway Management for Platelet-Rich Plasma Therapy in Kellgren-Lawrence Grade I and II Knee Osteoarthritis: A Prospective, Multicenter, Double-Blind Randomized Controlled Trial. Am J Sports Med. 2026 Oct 26. doi:10.1177/03635465261486945. PMID 42929654. Read the original

Frequently asked questions

Does this study prove PRP works for knee arthritis?: No. Both groups received PRP and there was no placebo group, so the trial only shows that the standardized pathway did better than usual PRP care, not that PRP itself is effective.
What was different about the standardized PRP pathway?: It combined standardized patient selection, quality-controlled leukocyte-poor PRP, ultrasound-guided injections, staged rehabilitation and systematic follow-up.
Who was included in the trial?: 240 patients with early knee osteoarthritis, rated Kellgren-Lawrence grade I or II, treated at 3 hospitals in China.

Sudden severe pain, swelling, or can't bear weight? Seek medical care promptly. In an emergency call 911.